Hhlr Advisors, Ltd. Nkarta, Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$26.67 - $38.76 $7.41 Million - $10.8 Million	-277,778 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$23.94 - $36.68 $1.96 Million - $3 Million	-81,750 Reduced 22.74%	277,778 $8.8 Million
Q1 2021 May 17, 2021	SELL	$31.33 - $59.61 $6.14 Million - $11.7 Million	-196,028 Reduced 35.29%	359,528 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$23.52 - $47.9 $13.1 Million - $26.6 Million	555,556 New	555,556 $16.7 Million

120

66.2M

142K

43.1K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $220M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.